Intellectual Property Magazine
SCOTUS denial hands Eli Lilly cancer drug win
Ben Wodecki
The Supreme Court of the US (SCOTUS) has denied hearingpetitions from Hospira and Dr Reddy's Laboratories who both sought
to overturn rulingshanded down by the Court of Appeals for the Federal Circuit (CAFC) relating topatent infringement of the
Eli Lilly cancer drug, Alimta.